E-LIB Suche - Ergebnisse für: Toriumi, Ren

1

Bone Turnover Markers, n-Terminal Propeptide of Type I Proc..:

Kano, Hiroshi ; Izumi, Kouji ; Nakagawa, Ryunosuke...
Biomedicines. 12 (2024) 2 - p. 292 , 2024

Link: https://doi.org/10.3390/..

2

Comprehensive analysis of perioperative hypotension in phot..:

Nohara, Takahiro ; Takimoto, Atsuya ; Shinzawa, Rei...
International Journal of Urology. , 2024

Link: https://doi.org/10.1111/..

3

Does radical cystectomy have a better prognosis than bladde..:

Nakagawa, Ryunosuke ; Izumi, Kouji ; Toriumi, Ren...
International Journal of Urology. 31 (2024) 6 - p. 628-636 , 2024

Link: https://doi.org/10.1111/..

4

Ischemic proctitis after low‐dose‐rate brachytherapy using ..:

Toriumi, Ren ; Yaegashi, Hiroshi ; Sakurai, Takayuki...
IJU Case Reports. 5 (2022) 4 - p. 237-240 , 2022

Link: https://doi.org/10.1002/..

5

Long response duration to pembrolizumab in metastatic, cast..:

Yoshida, Tsukasa ; Yaegashi, Hiroshi ; Toriumi, Ren...
Frontiers in Oncology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

6

Suppression of androgen receptor signaling induces prostate..:

Kano, Hiroshi ; Izumi, Kouji ; Hiratsuka, Kaoru...
Cancer Science. 114 (2022) 4 - p. 1479-1490 , 2022

Link: https://doi.org/10.1111/..

7

Usefulness of serum CCL2 as prognostic biomarker in prostat..:

Iwamoto, Hiroaki ; Izumi, Kouji ; Nakagawa, Ryunosuke...
Japanese Journal of Clinical Oncology. , 2022

Link: https://doi.org/10.1093/..

8

Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Cas..:

Iwamoto, Hiroaki ; Izumi, Kouji ; Nakagawa, Ryunosuke...
Biomedicines. 10 (2022) 10 - p. 2369 , 2022

Link: https://doi.org/10.3390/..

9

Decreased febrile neutropenia during inpatient chemotherapy..:

Toriumi, Ren ; Yaegashi, Hiroshi ; Kadomoto, Suguru...
Cancer Science. 114 (2022) 1 - p. 201-210 , 2022

Link: https://doi.org/10.1111/..

10

Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Cas..:

Iwamoto, Hiroaki ; Izumi, Kouji ; Nakagawa, Ryunosuke...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598117/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Ischemic proctitis after low‐dose‐rate brachytherapy using ..:

Toriumi, Ren ; Yaegashi, Hiroshi ; Sakurai, Takayuki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249642/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Suppression of androgen receptor signaling induces prostate..:

Kano, Hiroshi ; Izumi, Kouji ; Hiratsuka, Kaoru...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067408/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Long response duration to pembrolizumab in metastatic, cast..:

Tsukasa Yoshida ; Hiroshi Yaegashi ; Ren Toriumi...
https://www.frontiersin.org/articles/10.3389/fonc.2022.912490/full. , 2022

Link: https://doi.org/10.3389/..

14

Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Cas..:

Hiroaki Iwamoto ; Kouji Izumi ; Ryunosuke Nakagawa...
https://www.mdpi.com/2227-9059/10/10/2369. , 2022

Link: https://doi.org/10.3390/..

15

Ischemic proctitis after low‐dose‐rate brachytherapy using ..:

Ren Toriumi ; Hiroshi Yaegashi ; Takayuki Sakurai...
https://doi.org/10.1002/iju5.12444. , 2022

Link: https://doi.org/10.1002/..